img

Global Viral Vector Manufacturing Services Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Viral Vector Manufacturing Services Market Research Report 2024

According to MRAResearch’s new survey, global Viral Vector Manufacturing Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Viral Vector Manufacturing Services market research.
Key companies engaged in the Viral Vector Manufacturing Services industry include Novasep, Lonza Pharma & Biotech, ABL, Inc., Takara Bio, Sartorius, Cobra Biologics, Finvector, Fujifilm Diosynth Biotechnologies and Sanofi, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Viral Vector Manufacturing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Viral Vector Manufacturing Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Viral Vector Manufacturing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novasep
Lonza Pharma & Biotech
ABL, Inc.
Takara Bio
Sartorius
Cobra Biologics
Finvector
Fujifilm Diosynth Biotechnologies
Sanofi
Spark Therapeutics
uniQure
Segment by Type
Retroviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Other Viral Vectors

Segment by Application


Pharmaceutical and Biopharmaceutical Companies
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Viral Vector Manufacturing Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Manufacturing Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Retroviral Vectors
1.2.3 Adenoviral Vectors
1.2.4 Adeno-associated Viral Vectors
1.2.5 Other Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vector Manufacturing Services Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical and Biopharmaceutical Companies
1.3.3 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Manufacturing Services Market Perspective (2018-2033)
2.2 Viral Vector Manufacturing Services Growth Trends by Region
2.2.1 Global Viral Vector Manufacturing Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Viral Vector Manufacturing Services Historic Market Size by Region (2018-2023)
2.2.3 Viral Vector Manufacturing Services Forecasted Market Size by Region (2024-2033)
2.3 Viral Vector Manufacturing Services Market Dynamics
2.3.1 Viral Vector Manufacturing Services Industry Trends
2.3.2 Viral Vector Manufacturing Services Market Drivers
2.3.3 Viral Vector Manufacturing Services Market Challenges
2.3.4 Viral Vector Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Manufacturing Services Players by Revenue
3.1.1 Global Top Viral Vector Manufacturing Services Players by Revenue (2018-2023)
3.1.2 Global Viral Vector Manufacturing Services Revenue Market Share by Players (2018-2023)
3.2 Global Viral Vector Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Manufacturing Services Revenue
3.4 Global Viral Vector Manufacturing Services Market Concentration Ratio
3.4.1 Global Viral Vector Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Services Revenue in 2022
3.5 Viral Vector Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Viral Vector Manufacturing Services Product Solution and Service
3.7 Date of Enter into Viral Vector Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Manufacturing Services Breakdown Data by Type
4.1 Global Viral Vector Manufacturing Services Historic Market Size by Type (2018-2023)
4.2 Global Viral Vector Manufacturing Services Forecasted Market Size by Type (2024-2033)
5 Viral Vector Manufacturing Services Breakdown Data by Application
5.1 Global Viral Vector Manufacturing Services Historic Market Size by Application (2018-2023)
5.2 Global Viral Vector Manufacturing Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Viral Vector Manufacturing Services Market Size (2018-2033)
6.2 North America Viral Vector Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Viral Vector Manufacturing Services Market Size by Country (2018-2023)
6.4 North America Viral Vector Manufacturing Services Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Manufacturing Services Market Size (2018-2033)
7.2 Europe Viral Vector Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Viral Vector Manufacturing Services Market Size by Country (2018-2023)
7.4 Europe Viral Vector Manufacturing Services Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Manufacturing Services Market Size (2018-2033)
8.2 Asia-Pacific Viral Vector Manufacturing Services Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Viral Vector Manufacturing Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Viral Vector Manufacturing Services Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Manufacturing Services Market Size (2018-2033)
9.2 Latin America Viral Vector Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Viral Vector Manufacturing Services Market Size by Country (2018-2023)
9.4 Latin America Viral Vector Manufacturing Services Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Manufacturing Services Market Size (2018-2033)
10.2 Middle East & Africa Viral Vector Manufacturing Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Viral Vector Manufacturing Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Viral Vector Manufacturing Services Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novasep
11.1.1 Novasep Company Detail
11.1.2 Novasep Business Overview
11.1.3 Novasep Viral Vector Manufacturing Services Introduction
11.1.4 Novasep Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.1.5 Novasep Recent Development
11.2 Lonza Pharma & Biotech
11.2.1 Lonza Pharma & Biotech Company Detail
11.2.2 Lonza Pharma & Biotech Business Overview
11.2.3 Lonza Pharma & Biotech Viral Vector Manufacturing Services Introduction
11.2.4 Lonza Pharma & Biotech Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.2.5 Lonza Pharma & Biotech Recent Development
11.3 ABL, Inc.
11.3.1 ABL, Inc. Company Detail
11.3.2 ABL, Inc. Business Overview
11.3.3 ABL, Inc. Viral Vector Manufacturing Services Introduction
11.3.4 ABL, Inc. Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.3.5 ABL, Inc. Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Detail
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Viral Vector Manufacturing Services Introduction
11.4.4 Takara Bio Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.4.5 Takara Bio Recent Development
11.5 Sartorius
11.5.1 Sartorius Company Detail
11.5.2 Sartorius Business Overview
11.5.3 Sartorius Viral Vector Manufacturing Services Introduction
11.5.4 Sartorius Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.5.5 Sartorius Recent Development
11.6 Cobra Biologics
11.6.1 Cobra Biologics Company Detail
11.6.2 Cobra Biologics Business Overview
11.6.3 Cobra Biologics Viral Vector Manufacturing Services Introduction
11.6.4 Cobra Biologics Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.6.5 Cobra Biologics Recent Development
11.7 Finvector
11.7.1 Finvector Company Detail
11.7.2 Finvector Business Overview
11.7.3 Finvector Viral Vector Manufacturing Services Introduction
11.7.4 Finvector Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.7.5 Finvector Recent Development
11.8 Fujifilm Diosynth Biotechnologies
11.8.1 Fujifilm Diosynth Biotechnologies Company Detail
11.8.2 Fujifilm Diosynth Biotechnologies Business Overview
11.8.3 Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Services Introduction
11.8.4 Fujifilm Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.8.5 Fujifilm Diosynth Biotechnologies Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Viral Vector Manufacturing Services Introduction
11.9.4 Sanofi Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 Spark Therapeutics
11.10.1 Spark Therapeutics Company Detail
11.10.2 Spark Therapeutics Business Overview
11.10.3 Spark Therapeutics Viral Vector Manufacturing Services Introduction
11.10.4 Spark Therapeutics Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.10.5 Spark Therapeutics Recent Development
11.11 uniQure
11.11.1 uniQure Company Detail
11.11.2 uniQure Business Overview
11.11.3 uniQure Viral Vector Manufacturing Services Introduction
11.11.4 uniQure Revenue in Viral Vector Manufacturing Services Business (2018-2023)
11.11.5 uniQure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Viral Vector Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Adenoviral Vectors
Table 4. Key Players of Adeno-associated Viral Vectors
Table 5. Key Players of Other Viral Vectors
Table 6. Global Viral Vector Manufacturing Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Viral Vector Manufacturing Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Viral Vector Manufacturing Services Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Viral Vector Manufacturing Services Market Share by Region (2018-2023)
Table 10. Global Viral Vector Manufacturing Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Viral Vector Manufacturing Services Market Share by Region (2024-2033)
Table 12. Viral Vector Manufacturing Services Market Trends
Table 13. Viral Vector Manufacturing Services Market Drivers
Table 14. Viral Vector Manufacturing Services Market Challenges
Table 15. Viral Vector Manufacturing Services Market Restraints
Table 16. Global Viral Vector Manufacturing Services Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Viral Vector Manufacturing Services Market Share by Players (2018-2023)
Table 18. Global Top Viral Vector Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing Services as of 2022)
Table 19. Ranking of Global Top Viral Vector Manufacturing Services Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Viral Vector Manufacturing Services Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Viral Vector Manufacturing Services Product Solution and Service
Table 23. Date of Enter into Viral Vector Manufacturing Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Viral Vector Manufacturing Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Viral Vector Manufacturing Services Revenue Market Share by Type (2018-2023)
Table 27. Global Viral Vector Manufacturing Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Viral Vector Manufacturing Services Revenue Market Share by Type (2024-2033)
Table 29. Global Viral Vector Manufacturing Services Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Viral Vector Manufacturing Services Revenue Market Share by Application (2018-2023)
Table 31. Global Viral Vector Manufacturing Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Viral Vector Manufacturing Services Revenue Market Share by Application (2024-2033)
Table 33. North America Viral Vector Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Viral Vector Manufacturing Services Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Viral Vector Manufacturing Services Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Viral Vector Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Viral Vector Manufacturing Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Viral Vector Manufacturing Services Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Viral Vector Manufacturing Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Viral Vector Manufacturing Services Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Viral Vector Manufacturing Services Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Viral Vector Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Viral Vector Manufacturing Services Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Viral Vector Manufacturing Services Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Viral Vector Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Viral Vector Manufacturing Services Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Viral Vector Manufacturing Services Market Size by Country (2024-2033) & (US$ Million)
Table 48. Novasep Company Detail
Table 49. Novasep Business Overview
Table 50. Novasep Viral Vector Manufacturing Services Product
Table 51. Novasep Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 52. Novasep Recent Development
Table 53. Lonza Pharma & Biotech Company Detail
Table 54. Lonza Pharma & Biotech Business Overview
Table 55. Lonza Pharma & Biotech Viral Vector Manufacturing Services Product
Table 56. Lonza Pharma & Biotech Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 57. Lonza Pharma & Biotech Recent Development
Table 58. ABL, Inc. Company Detail
Table 59. ABL, Inc. Business Overview
Table 60. ABL, Inc. Viral Vector Manufacturing Services Product
Table 61. ABL, Inc. Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 62. ABL, Inc. Recent Development
Table 63. Takara Bio Company Detail
Table 64. Takara Bio Business Overview
Table 65. Takara Bio Viral Vector Manufacturing Services Product
Table 66. Takara Bio Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 67. Takara Bio Recent Development
Table 68. Sartorius Company Detail
Table 69. Sartorius Business Overview
Table 70. Sartorius Viral Vector Manufacturing Services Product
Table 71. Sartorius Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 72. Sartorius Recent Development
Table 73. Cobra Biologics Company Detail
Table 74. Cobra Biologics Business Overview
Table 75. Cobra Biologics Viral Vector Manufacturing Services Product
Table 76. Cobra Biologics Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 77. Cobra Biologics Recent Development
Table 78. Finvector Company Detail
Table 79. Finvector Business Overview
Table 80. Finvector Viral Vector Manufacturing Services Product
Table 81. Finvector Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 82. Finvector Recent Development
Table 83. Fujifilm Diosynth Biotechnologies Company Detail
Table 84. Fujifilm Diosynth Biotechnologies Business Overview
Table 85. Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Services Product
Table 86. Fujifilm Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 87. Fujifilm Diosynth Biotechnologies Recent Development
Table 88. Sanofi Company Detail
Table 89. Sanofi Business Overview
Table 90. Sanofi Viral Vector Manufacturing Services Product
Table 91. Sanofi Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Spark Therapeutics Company Detail
Table 94. Spark Therapeutics Business Overview
Table 95. Spark Therapeutics Viral Vector Manufacturing Services Product
Table 96. Spark Therapeutics Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 97. Spark Therapeutics Recent Development
Table 98. uniQure Company Detail
Table 99. uniQure Business Overview
Table 100. uniQure Viral Vector Manufacturing Services Product
Table 101. uniQure Revenue in Viral Vector Manufacturing Services Business (2018-2023) & (US$ Million)
Table 102. uniQure Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vector Manufacturing Services Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Viral Vector Manufacturing Services Market Share by Type: 2022 VS 2033
Figure 3. Retroviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Adeno-associated Viral Vectors Features
Figure 6. Other Viral Vectors Features
Figure 7. Global Viral Vector Manufacturing Services Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Viral Vector Manufacturing Services Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical and Biopharmaceutical Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Viral Vector Manufacturing Services Report Years Considered
Figure 12. Global Viral Vector Manufacturing Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Viral Vector Manufacturing Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Viral Vector Manufacturing Services Market Share by Region: 2022 VS 2033
Figure 15. Global Viral Vector Manufacturing Services Market Share by Players in 2022
Figure 16. Global Top Viral Vector Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing Services as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Services Revenue in 2022
Figure 18. North America Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Viral Vector Manufacturing Services Market Share by Country (2018-2033)
Figure 20. United States Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Viral Vector Manufacturing Services Market Share by Country (2018-2033)
Figure 24. Germany Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Viral Vector Manufacturing Services Market Share by Region (2018-2033)
Figure 32. China Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Viral Vector Manufacturing Services Market Share by Country (2018-2033)
Figure 40. Mexico Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Viral Vector Manufacturing Services Market Share by Country (2018-2033)
Figure 44. Turkey Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Viral Vector Manufacturing Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Novasep Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 47. Lonza Pharma & Biotech Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 48. ABL, Inc. Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 49. Takara Bio Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 50. Sartorius Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 51. Cobra Biologics Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 52. Finvector Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 53. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 55. Spark Therapeutics Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 56. uniQure Revenue Growth Rate in Viral Vector Manufacturing Services Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed